Capital Flow Monitor · Sponsors · CIK 1852167
Adela, Inc.
353 HATCH DRIVE, FOSTER CITY, CA, 94404 · (888) 210-1773
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$27.0M
Sold
$25.4M
% sold
94.2%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | D | 506(b) | $5.0M | $5.0M | 100.0% | 1 | EDGAR ↗ |
| 2025-07-08 | D ·current | 506(b) | $27.0M | $25.4M | 94.2% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Lisa Alderson — Executive Officer / Director, Foster City, CA
-
David Bonita — Director, Foster City, CA
6 other raises
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
- Alpfa Medical, Inc. $80.3M of $100.3M · 80.1%
- OrbiMed Partners II, L.P. $1.78B of —
- Thrombolex, Inc. $32.8M of $51.1M · 64.1%
- Treeline Biosciences, Inc. $200.1M of $250.0M · 80.0%
- Ikena Oncology, Inc. $0 of $75.0M · 0.0%
-
Paul Brown — Director, Foster City, CA
2 other raises
- Georgiamune, Inc. $92.7M of $131.9M · 70.3%
- Events.com, Inc. $6.8M of $6.8M · 100.0%
- Daniel Diniz De Carvalho — Executive Officer / Promoter, Foster City, CA
-
Andrew ElBardissi — Director, Foster City, CA
1 other raise
- Alpfa Medical, Inc. $80.3M of $100.3M · 80.1%
- Anne-Renee Hartman — Executive Officer, Foster City, CA
- Priscilla Huang — Executive Officer, Foster City, CA
-
Maneesh Jain — Director / Promoter, Foster City, CA
2 other raises
- Keepsake Capital Partners, LP $861K of —
- Mirvie, Inc. $23.7M of $30.0M · 79.0%
-
David Scheer — Executive Officer / Director / Promoter, Foster City, CA
1 other raise
- ThirdLaw Molecular, Inc. $5.5M of $5.5M · 100.0%
-
Robert Weisskoff — Director, Foster City, CA
1 other raise
- Affinia Therapeutics Inc. $13.3M of $45.0M · 29.5%
- Alan Williams — Executive Officer, Foster City, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.